This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Philips And Biocompatibles Team-up To Advance Image Guided Transarterial Embolizations In Interventional Oncology

Stocks in this article: PHG PHI

AMSTERDAM and FARNHAM, England, September 14, 2012 /PRNewswire/ --

Launch of collaboration marked with development of new treatment protocol for trans-arterial embolization in hypervascular tumors

Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Biocompatibles, a BTG international group company, announced a collaboration to advance the use of image guidance to control the delivery of beads during the arterial embolization of hypervascularized tumors today at the annual CIRSE (Cardiovascular and Interventional Radiological Society of Europe) meeting.

The first undertaking* of this new collaboration will be the development of a new treatment protocol for trans-arterial embolization - a process demonstrated to reduce the size or rate of growth of tumors. This is done by blocking the blood supply to a tumor (embolization) using an embolic material (in this case, beads). The aim of this protocol is to standardize and optimize the current approach to treatment delivery, thereby ensuring the best possible patient outcome.

The trend towards such minimally invasive treatments continues to grow in interventional oncology. This requires an integrated approach from image guidance and medical devices to provide controlled delivery of treatment that will both enable physicians to perform their procedures with more precision, and reduce discomfort for the patient.

"Personalized and less invasive treatment is the way forward in patient care," says Louise Verheij, VP Marketing BU iXR. "As part of our strategy, Philips is committed to delivering integrated interventional solutions for image-guided minimally invasive procedures by working closely with hospitals and industry partners in different application spaces. Combining the leadership positions of Philips, in the field of advanced image guidance, and Biocompatibles, in the field of embolization beads, we strive to deliver reproducible and quantifiable results in Image Guided Interventional Oncology. This is an important step in helping advance patient care."

"As a leader in beads for interventional oncology, we are investing in the optimization techniques used for embolization procedures in order to further improve the safety and efficacy of the procedure at a macro level," says Mike Motion, General Manager Interventional Oncology of Biocompatibles. "Partnering with Philips will strengthen our ability to develop integrated techniques and image guidance to enhance the arterial embolization of hypervascularized tumors with beads, the ultimate objective being the advancement of interventional oncology."

* Further to the planned protocol development, the scope of collaboration and development activities between Philips and BTG is currently being finalized, with additional announcements expected to be made in 2013

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,651.97 -20.63 -0.12%
S&P 500 2,051.58 -0.24 -0.01%
NASDAQ 4,760.77 +2.8910 0.06%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs